Skip to content

Clinical trials

Completed Pathologic Complete Response trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Complete Response Status: Completed Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20191
20203
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sixth Affiliated Hospital, Sun Yat-sen University2
307 Hospital of PLA1
Peking Union Medical College Hospital1
Peking University Cancer Hospital & Institute1
Ruijin Hospital1
Shanghai Jiao Tong University School of Medicine1
Zhejiang Cancer Hospital1
Zilong Yuan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Complete Response9
Breast Neoplasms3
Rectal Neoplasms2
Esophageal Squamous Cell Carcinoma1
Pathological Conditions, Signs and Symptoms1
Retroperitoneal Fibrosis1
Squamous Cell Carcinoma of Head and Neck1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.